Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 28.90
-2.32 (-7.43%)
Sep 10, 2026, 11:59 AM HKT
Everest Medicines Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Everest Medicines stock has a consensus rating of "Buy" and an average price target of $40.66. The average 1-year stock price forecast is 40.69% higher than the current stock price, while the lowest is $25.82 (-10.66%) and the highest is $69.70 (+141.18%).
Price Target: $40.66 (+40.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Everest Medicines stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $68.00 | Buy | Maintains | $68.00 | +135.29% | Aug 27, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $43.82 | Buy | Maintains | $43.82 | +51.63% | Aug 26, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $41.50 | Buy | Maintains | $41.50 | +43.60% | Aug 22, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $84.00 → $66.00 | Buy | Maintains | $84.00 → $66.00 | +128.37% | Aug 21, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Hold Maintains $32.70 | Hold | Maintains | $32.70 | +13.15% | Jun 17, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 1.71B
Increased by 87.35%
Revenue Next Year
4.08B
from 3.20B
Increased by 27.63%
EPS This Year
0.41
from 0.56
Decreased by -26.30%
EPS Next Year
1.16
from 0.41
Increased by 182.93%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.